Table 1_Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation.xlsx

Table 1_Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation.xlsx

<p>Triple-negative breast cancer (TNBC) remains a clinically aggressive subtype of breast cancer, defined by the absence of estrogen receptor, progesterone receptor, and HER2 amplification, and disproportionately affecting younger and racially diverse populations. Despite conventional chemothe...

पूर्ण विवरण

में बचाया:

ग्रंथसूची विवरण
मुख्य लेखक:	Yueren Fan (22687577) (author)
अन्य लेखक:	He Wang (250350) (author), Hongyu Zhang (155876) (author), Tianfei Ma (22687580) (author), Yihang Zhao (6743393) (author)
प्रकाशित:	2025
विषय:	Genetic Immunology triple-negative breast cancer tumor-infiltrating lymphocytes antibody-drug conjugates immunotherapy antitumor immunity
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन

Supplementary file 1_Minimally expanded breast cancer tumor-infiltrating-lymphocytes provide guidance for therapeutic selection.docx
द्वारा: Andrea Aran (11711939)
प्रकाशित: (2025)

Data Sheet 1_Minimally expanded breast cancer tumor-infiltrating-lymphocytes provide guidance for therapeutic selection.xlsx
द्वारा: Andrea Aran (11711939)
प्रकाशित: (2025)

Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Figure S2 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Figure S3 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Figure S4 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Figure S5 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Figure S6 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Supplemental Tables 1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
द्वारा: Martina S.J. McDermott (15206951)
प्रकाशित: (2025)

Supplementary Tables from Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
द्वारा: Santiago Duro-Sánchez (14959182)
प्रकाशित: (2025)

Potent phenolics with antimigratory and anti-MRSA powers from fungus associated with <i>Saussurea involucrata</i>
द्वारा: Wei-hua Yuan (22683169)
प्रकाशित: (2025)

Figures S1-S2 from Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
द्वारा: Sheheryar Kabraji (15050565)
प्रकाशित: (2025)

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S2 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S3 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S4 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S5 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S6 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
द्वारा: Yuncheng Bei (16546095)
प्रकाशित: (2025)

Supplementary Table S1 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
द्वारा: Yuncheng Bei (16546095)
प्रकाशित: (2025)

Supplementary Table S3 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
द्वारा: Yuncheng Bei (16546095)
प्रकाशित: (2025)

Supplementary Table S1 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
द्वारा: Erwin Tomasich (15052256)
प्रकाशित: (2025)

Supplementary Table S2 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
द्वारा: Erwin Tomasich (15052256)
प्रकाशित: (2025)

Supplementary Table S3 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
द्वारा: Erwin Tomasich (15052256)
प्रकाशित: (2025)

Supplementary Table S4 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
द्वारा: Erwin Tomasich (15052256)
प्रकाशित: (2025)

Supplementary Table S5 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
द्वारा: Erwin Tomasich (15052256)
प्रकाशित: (2025)

Supplementary Table S6 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
द्वारा: Erwin Tomasich (15052256)
प्रकाशित: (2025)

Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
द्वारा: Niklas Klümper (15048887)
प्रकाशित: (2025)

Supplementary Data TS1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
द्वारा: Niklas Klümper (15048887)
प्रकाशित: (2025)

Discovery and Characterization of Novel BLIMP‑1 Heterobifunctional Ligand-Directed Degraders
द्वारा: Bryan J. Simmons (22676881)
प्रकाशित: (2025)

Image 1_APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration.jpeg
द्वारा: Jianting Man (22678730)
प्रकाशित: (2025)

Table 3_APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration.docx
द्वारा: Jianting Man (22678730)
प्रकाशित: (2025)

Table 4_APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration.docx
द्वारा: Jianting Man (22678730)
प्रकाशित: (2025)

Table 1_APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration.docx
द्वारा: Jianting Man (22678730)
प्रकाशित: (2025)

Table 2_APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration.docx
द्वारा: Jianting Man (22678730)
प्रकाशित: (2025)

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
द्वारा: Rui Wang (52434)
प्रकाशित: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
द्वारा: Rui Wang (52434)
प्रकाशित: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
द्वारा: Rui Wang (52434)
प्रकाशित: (2025)

Cannot write session to /tmp/vufind_sessions/sess_drvnpg474m9rg23do963akdjv8